Akebia’s Vafseo: Japanese Postmarketing Data, Narrowed Indication Eased Liver Toxicity Worries

 
• By Sue Sutter
  
Drug Review Profile: Vafseo
The FDA approved Akebia's Vafseo for treatment of anemia in chronic kidney disease patients on dialysis. • Source: Shutterstock
Pink Sheet Podcast

Have you checked out Pink Sheet podcast?

New episodes every Thursday.

SpotifyApple PodcastsWebsite

More from Drug Review Profiles

More from Product Reviews